OpenLegislation

Chapter 3 PharmacovigilanceF1

United Kingdom Repealed

Original text. Later amendments are not shown.

  1. 21Article 21
  2. 22Article 22
  3. 23Article 23
  4. 24Article 24
  5. 25Article 25
  6. 25aArticle 25a
  7. 26Article 26
  8. 27Article 27
  9. 28Article 28
  10. 28aArticle 28a
  11. 28bArticle 28b
  12. 28cArticle 28c
  13. 28dArticle 28d
  14. 28eArticle 28e
  15. 28fArticle 28f
  16. 29Article 29

Annotations

Textual amendments

F1

Regulation revoked insofar as it applies to medicinal products for veterinary use (31.12.2020) by The Veterinary Medicines and Animals and Animal Products (Examination of Residues and Maximum Residue Limits) (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/676), regs. 1(2)(b), 5; 2020 c. 1, Sch. 5 para. 1(1)

Regulation revoked insofar as it applies to medicinal products for human use (31.12.2020) by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2019 (S.I. 2019/775), Sch. 9 para. 1(h) (subject to transitional provisions in S.I. 2012/1916, Sch. 33A); 2020 c. 1, Sch. 5 para. 1(1)